FDA grants Breakthrough Device Designation for Apollo’s Orbera Balloon for NASH treatmentApollo Endosurgery has received a Breakthrough Device Designation from the FDA for the Orbera Intragastric Balloon, specifically for the...
GLP-1s associated with higher risk of major depression, increased risk for anxiety and an elevated risk for suicidal behaviour1 day ago